dactinomycin has been researched along with Angiogenesis, Pathologic in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (30.77) | 18.2507 |
| 2000's | 8 (61.54) | 29.6817 |
| 2010's | 1 (7.69) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Deacon, K; Knox, AJ; Kumari, R; Onion, D; Watson, SA | 1 |
| Lenzi, M; Schwartz, EL; Zhu, GH | 1 |
| Cao, G; Coukos, G; Fracchioli, S; Katsaros, D; O'Brien-Jenkins, A; Park, JW; Randall, TC; Rubin, SC; Yang, N; Zhang, L | 1 |
| Detrick, B; Hooks, JJ; Nagineni, CN; Nagineni, S; Pardhasaradhi, K; Samuel, W; Wiggert, B | 1 |
| Abcouwer, SF; Hurtado, D; Roybal, CN; Sun, CW; Townes, TM; Vander Jagt, DL; Yang, S | 1 |
| Glazer, RI; Hannay, J; Liu, J; Pollock, RE; Yu, D; Zhan, M | 1 |
| Handa, Y; Kubota, T; Matsukawa, S; Sato, K; Takeuchi, H; Yao, Y | 1 |
| Cash, J; Fraizer, G; Gorman, J; Korchnak, A; Tandon, Y | 1 |
| Maciag, T; Villeponteau, B; Zimrin, AB | 1 |
| Adamis, AP; Amano, S; Beerepoot, LV; Colby, KA; Kim, RY; Kuroki, M; Rohan, RM; Takashima, S; Tolentino, M; Voest, EE; Yeo, KT | 1 |
| Linder, S; Ljungdahl, S; Shoshan, MC; Swedenborg, J; Zhou, JN | 1 |
| Kuakuvi, N; Ndiaye, O; Ndiaye, P; Sall, G; Sylla, A | 1 |
| Hu, L; Huang, YQ; Karpatkin, S; Lee, M; Li, JJ | 1 |
1 trial(s) available for dactinomycin and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Elevated SP-1 transcription factor expression and activity drives basal and hypoxia-induced vascular endothelial growth factor (VEGF) expression in non-small cell lung cancer.
Topics: Carcinoma, Non-Small-Cell Lung; Cell Hypoxia; Cell Line, Tumor; Dactinomycin; Female; Gene Expression Regulation, Neoplastic; Histones; Humans; Hypoxia; Lung Neoplasms; Male; Neoplasm Proteins; Neovascularization, Pathologic; Nucleic Acid Synthesis Inhibitors; p300-CBP Transcription Factors; Promoter Regions, Genetic; Protein Binding; Sp1 Transcription Factor; Vascular Endothelial Growth Factor A | 2012 |
12 other study(ies) available for dactinomycin and Angiogenesis, Pathologic
| Article | Year |
|---|---|
The Sp1 transcription factor contributes to the tumor necrosis factor-induced expression of the angiogenic factor thymidine phosphorylase in human colon carcinoma cells.
Topics: Adenocarcinoma; Base Sequence; Colonic Neoplasms; Dactinomycin; DNA Primers; DNA Probes; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; Kinetics; Mutagenesis, Site-Directed; Neovascularization, Pathologic; Polymerase Chain Reaction; RNA, Messenger; Sp1 Transcription Factor; Thymidine Phosphorylase; Transcription, Genetic; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 2002 |
Tumor-derived vascular endothelial growth factor up-regulates angiopoietin-2 in host endothelium and destabilizes host vasculature, supporting angiogenesis in ovarian cancer.
Topics: Angiogenesis Inducing Agents; Angiopoietin-1; Angiopoietin-2; Animals; Carcinoma; Cell Line, Transformed; Dactinomycin; Endothelial Growth Factors; Endothelium, Vascular; Female; Gene Expression Regulation, Neoplastic; Genes, Reporter; Humans; Intercellular Signaling Peptides and Proteins; Lymphokines; Membrane Glycoproteins; Mice; Mice, Inbred C57BL; Models, Biological; Neoplasm Proteins; Neovascularization, Pathologic; Nucleic Acid Synthesis Inhibitors; Ovarian Neoplasms; Paracrine Communication; Pericytes; Receptor Protein-Tyrosine Kinases; Receptor, TIE-2; Recombinant Fusion Proteins; RNA, Messenger; RNA, Neoplasm; Stromal Cells; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2003 |
Transforming growth factor-beta induces expression of vascular endothelial growth factor in human retinal pigment epithelial cells: involvement of mitogen-activated protein kinases.
Topics: Antibodies; Cells, Cultured; Choroid; Dactinomycin; Dose-Response Relationship, Drug; Enzyme Inhibitors; Fibroblasts; Humans; MAP Kinase Signaling System; Matrix Metalloproteinases; Neovascularization, Pathologic; Pigment Epithelium of Eye; Protein Isoforms; Protein Serine-Threonine Kinases; Receptor, Transforming Growth Factor-beta Type II; Receptors, Transforming Growth Factor beta; Retinal Diseases; RNA, Messenger; Signal Transduction; Transforming Growth Factor beta; Vascular Endothelial Growth Factor A | 2003 |
Homocysteine increases the expression of vascular endothelial growth factor by a mechanism involving endoplasmic reticulum stress and transcription factor ATF4.
Topics: Activating Transcription Factor 4; Blotting, Northern; Blotting, Western; Carrier Proteins; CCAAT-Enhancer-Binding Proteins; Cell Line; Cell Nucleus; Dactinomycin; DNA, Complementary; Dose-Response Relationship, Drug; Endoplasmic Reticulum; Endoplasmic Reticulum Chaperone BiP; Enzyme-Linked Immunosorbent Assay; Epithelial Cells; Genes, Dominant; Heat-Shock Proteins; Homocysteine; Humans; Molecular Chaperones; Mutation; Neovascularization, Pathologic; Nucleic Acid Synthesis Inhibitors; Phosphorylation; Promoter Regions, Genetic; Protein Binding; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Stress, Physiological; Time Factors; Transcription Factor CHOP; Transcription Factors; Transcription, Genetic; Up-Regulation; Vascular Endothelial Growth Factor A | 2004 |
Transcriptional repression of protein kinase Calpha via Sp1 by wild type p53 is involved in inhibition of multidrug resistance 1 P-glycoprotein phosphorylation.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Binding Sites; Blotting, Northern; Blotting, Western; Cell Line, Tumor; Cell Movement; Cell Nucleus; Cell Proliferation; Dactinomycin; Down-Regulation; Gene Deletion; Genes, p53; Genes, Reporter; Humans; Immunoprecipitation; Luciferases; Models, Genetic; Mutation; Neovascularization, Pathologic; Phosphorylation; Point Mutation; Promoter Regions, Genetic; Protein Binding; Protein Kinase C; Protein Kinase C-alpha; RNA; RNA, Messenger; Signal Transduction; Sp1 Transcription Factor; Temperature; Time Factors; Transcription, Genetic; Transfection; Tumor Suppressor Protein p53 | 2005 |
Cell-specific but p53-independent regulation of vascular endothelial growth factor expression by interferons in human glioblastoma cells.
Topics: Blotting, Western; Brain Neoplasms; Cell Line, Tumor; Cycloheximide; Dactinomycin; Enzyme-Linked Immunosorbent Assay; Glioblastoma; Humans; Interferons; Mitogen-Activated Protein Kinases; Neovascularization, Pathologic; Protein Synthesis Inhibitors; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tumor Suppressor Protein p53; Up-Regulation; Vascular Endothelial Growth Factor A | 2006 |
VEGF transcription and mRNA stability are altered by WT1 not DDS(R384W) expression in LNCaP cells.
Topics: Cell Line, Tumor; Dactinomycin; Denys-Drash Syndrome; Gene Expression Regulation, Neoplastic; Hormones; Humans; Male; Mutation; Neovascularization, Pathologic; Neovascularization, Physiologic; Prostatic Neoplasms; RNA Stability; Transcription, Genetic; Vascular Endothelial Growth Factor A; WT1 Proteins | 2007 |
Models of in vitro angiogenesis: endothelial cell differentiation on fibrin but not matrigel is transcriptionally dependent.
Topics: Base Sequence; Cell Differentiation; Cells, Cultured; Collagen; Culture Media; Cycloheximide; Dactinomycin; Drug Combinations; Endothelium, Vascular; Fibrin; Fibroblast Growth Factor 1; Humans; Laminin; Models, Biological; Molecular Sequence Data; Neovascularization, Pathologic; Proteoglycans; Transcription, Genetic; Umbilical Veins | 1995 |
Reactive oxygen intermediates increase vascular endothelial growth factor expression in vitro and in vivo.
Topics: Animals; Antioxidants; Cattle; Cells, Cultured; Cycloheximide; Dactinomycin; Endothelial Growth Factors; Enzyme Inhibitors; Gene Expression Regulation, Developmental; Glioblastoma; Half-Life; Humans; Hydrogen Peroxide; Lymphokines; Melanoma; Neovascularization, Pathologic; Neovascularization, Physiologic; Oxygen; Pigment Epithelium of Eye; Rabbits; Rats; Reactive Oxygen Species; Reperfusion; Retina; RNA, Messenger; Superoxides; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 1996 |
Activation of tissue-factor gene expression in breast carcinoma cells by stimulation of the RAF-ERK signaling pathway.
Topics: Base Sequence; Benzoquinones; Breast Neoplasms; Calcium-Calmodulin-Dependent Protein Kinases; Dactinomycin; DNA, Complementary; Enzyme Activation; Enzyme Induction; Enzyme Inhibitors; Female; Flavonoids; Gene Expression Regulation, Neoplastic; Genistein; Humans; Hydroquinones; Lactams, Macrocyclic; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Molecular Sequence Data; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Proteins; Neovascularization, Pathologic; NF-kappa B; Okadaic Acid; Phenols; Proto-Oncogene Proteins c-raf; Quinones; Rifabutin; Signal Transduction; Tetradecanoylphorbol Acetate; Thromboplastin; Transcription Factor AP-1; Transcription, Genetic; Tretinoin; Tumor Cells, Cultured | 1998 |
[Angiomyolipoma of the kidney].
Topics: Angiomyolipoma; Antineoplastic Combined Chemotherapy Protocols; Child, Preschool; Combined Modality Therapy; Dactinomycin; Doxorubicin; Female; Humans; Kidney Neoplasms; Neovascularization, Pathologic; Vincristine | 1998 |
Thrombin induces increased expression and secretion of VEGF from human FS4 fibroblasts, DU145 prostate cells and CHRF megakaryocytes.
Topics: Adenocarcinoma; Cells, Cultured; Dactinomycin; Endothelial Growth Factors; Fibroblasts; Gene Expression Regulation; Gene Expression Regulation, Neoplastic; Humans; Lymphokines; Male; Megakaryocytes; Neoplasm Proteins; Neovascularization, Pathologic; Nucleic Acid Synthesis Inhibitors; Prostate; Prostatic Neoplasms; RNA, Messenger; RNA, Neoplasm; Signal Transduction; Thrombin; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors | 2001 |